Recent Finacing
Recent Raise
Neurogene develops AAV vector–based gene therapies and novel delivery technologies for rare neurological diseases, collaborates with academic and patient groups, and builds GMP AAV manufacturing to advance clinical programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
